CRVS
Corvus Pharmaceuticals, Inc.$10.58-0.05 (-0.47%)Prev Close$10.64·MCap$895.8M·P/E—·Vol431.0K·Yield—
▲
Buys (12M)
3
$384.2K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$384.2K
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Corvus Pharmaceuticals, Inc. (CRVS) has been exclusively buying, with 3 insider purchases totaling $384.2K and 0 insider sales totaling $0.00. The most recent insider transaction was by Arcara Jeffrey (officer: Chief Business Officer), who purchased $50.5K worth of shares on Nov 13, 2026. Corvus Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $895.8M.
CRVS Insider Trading Activity
CRVS Insider Buying Activity
The following table shows recent insider purchases of Corvus Pharmaceuticals, Inc. (CRVS) stock reported via SEC Form 4 filings.
CRVS Insider Selling Activity
The following table shows recent insider sales of Corvus Pharmaceuticals, Inc. (CRVS) stock reported via SEC Form 4 filings.